Equillium, Inc. (EQ)
2.21
-0.06
(-2.64%)
USD |
NASDAQ |
Sep 01, 12:01
Equillium Cash from Operations (TTM) : -19.97M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -19.97M |
| March 31, 2026 | -18.88M |
| December 31, 2025 | -22.75M |
| September 30, 2025 | -22.91M |
| June 30, 2025 | -22.14M |
| March 31, 2025 | -18.40M |
| December 31, 2024 | -19.03M |
| September 30, 2024 | -21.39M |
| June 30, 2024 | -15.64M |
| March 31, 2024 | -22.59M |
| December 31, 2023 | -21.78M |
| September 30, 2023 | 11.61M |
| June 30, 2023 | 0.45M |
| March 31, 2023 | -4.594M |
| Date | Value |
|---|---|
| December 31, 2022 | -8.733M |
| September 30, 2022 | -46.59M |
| June 30, 2022 | -40.54M |
| March 31, 2022 | -36.27M |
| December 31, 2021 | -32.08M |
| September 30, 2021 | -30.20M |
| June 30, 2021 | -28.11M |
| March 31, 2021 | -26.20M |
| December 31, 2020 | -24.62M |
| September 30, 2020 | -25.40M |
| June 30, 2020 | -25.18M |
| March 31, 2020 | -24.86M |
| December 31, 2019 | -22.95M |
| September 30, 2019 | -17.74M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.56M |
| Fortress Biotech, Inc. | 120.36M |
| Cue Biopharma, Inc. | -50.05M |
| Legend Biotech Corp. | -182.95M |
| Dianthus Therapeutics, Inc. | -155.38M |